ANTIMICROBIAL SUSCEPTIBILITY PATTERNS OF STENOTROPHOMONAS MALTOPHILIA ISOLATED AT BAC NINH GENERAL HOSPITAL FROM 2019 TO 2023
Main Article Content
Abstract
Stenotrophomonas maltophilia represents a significant pathogenic threat, with increasing instances of antibiotic resistance among its strains. Method: This cross-sectional descriptive study endeavours to elucidate the epidemiological characteristics and antibiotic resistance profiles of S. maltophilia strains isolated at a provincial general hospital in Bac Ninh during the period from 2019 to 2023. Results: Of the 42 isolated strains, 59.5% were obtained from patients aged ≥60 years, 54.8% from males, 76.2% from Internal Medicine departments, and 73.8% from blood specimens. The resistance rates of S. maltophilia strains to Levofloxacin (LVX) and Trimethoprim-Sulfamethoxazole (SXT) were 5.7% and 11.9%, respectively. Notably, Intensive Care Units (ICUs) exhibited the highest rate of isolation of S. maltophilia strains resistant to antibiotics. Furthermore, strains resistant to LVX demonstrated universal resistance to SXT. Conclusions: the findings underscore the importance of exercising caution when utilizing LVX for treating infections caused by S. maltophilia. The study underscores the importance of prioritizing ongoing monitoring of antibiotic resistance and implementing robust infection control measures, not only to enhance treatment efficacy but also to mitigate the dissemination of resistant bacterial strains.
Article Details
References
2. Cho, S.Y., et al., Can levofloxacin be a useful alternative to trimethoprim-sulfamethoxazole for treating Stenotrophomonas maltophilia bacteremia? Antimicrob Agents Chemother, 2014. 58(1): p. 581-3.
3. Duan, Z., et al., Molecular epidemiology and risk factors of Stenotrophomonas maltophilia infections in a Chinese teaching hospital. BMC Microbiol, 2020. 20(1): p. 294.
4. Falagas, M.E., et al., Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature. Future Microbiol, 2009. 4(9): p. 1103-9.
5. Gales, A.C., et al., Antimicrobial Susceptibility of Acinetobacter calcoaceticus-Acinetobacter baumannii Complex and Stenotrophomonas maltophilia Clinical Isolates: Results From the SENTRY Antimicrobial Surveillance Program (1997-2016). Open Forum Infect Dis, 2019. 6 (Suppl 1): p. S34-S46.
6. Gulmez, D. and G. Hascelik, Stenotrophomonas maltophilia: antimicrobial resistance and molecular typing of an emerging pathogen in a Turkish university hospital. Clin Microbiol Infect, 2005. 11(11): p. 880-6.
7. Sader, H.S., et al., Frequency and antimicrobial susceptibility of Gram-negative bacteria isolated from patients with pneumonia hospitalized in ICUs of US medical centres (2015-17). J Antimicrob Chemother, 2018. 73(11): p. 3053-3059.
8. Wang, C.H., et al., Levofloxacin-resistant Stenotrophomonas maltophilia: risk factors and antibiotic susceptibility patterns in hospitalized patients. J Hosp Infect, 2020. 104(1): p. 46-52.